New hope for brain cancer: experimental combo enters human trials
NCT ID NCT06102525
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This early-stage trial tests a new drug called RZ-001 combined with valganciclovir in people with glioblastoma, an aggressive brain cancer. The study aims to find the safest dose and see if the treatment can shrink tumors or help people live longer. About 43 adults whose tumors have a specific marker (hTERT) will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact
-
Gachon University Gil Medical Center
RECRUITINGIncheon, 21565, South Korea
Contact
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
Contact
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, 13620, South Korea
Contact
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
Contact
-
The Catholic University of Korea, Incheon St. Mary's Hospital
RECRUITINGIncheon, 21431, South Korea
Contact
Conditions
Explore the condition pages connected to this study.